{"name":"CELL Technologies Inc.","slug":"cell-technologies-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Autologous Bone Marrow Aspirate Concentrate","genericName":"Autologous Bone Marrow Aspirate Concentrate","slug":"autologous-bone-marrow-aspirate-concentrate","indication":"Orthopedic injuries and degenerative joint disease (Phase 3 development)","status":"phase_3"}]}],"pipeline":[{"name":"Autologous Bone Marrow Aspirate Concentrate","genericName":"Autologous Bone Marrow Aspirate Concentrate","slug":"autologous-bone-marrow-aspirate-concentrate","phase":"phase_3","mechanism":"Autologous bone marrow aspirate concentrate delivers a patient's own bone marrow-derived cells (including mesenchymal stem cells and hematopoietic progenitors) to promote tissue repair and reduce inflammation.","indications":["Orthopedic injuries and degenerative joint disease (Phase 3 development)","Musculoskeletal tissue repair"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOTG9ORUJLc1JFRlNwRlRVWDZuVkZ0aV95MTQ1a0pJUUZxZV9nTG1COWFDSWJqQWlyRmtnaS1yNWcxa2NONFdWc3NkZ0RsaW80YlpjdW5wVHVXazBzNzhKc29UR0w5QWJSR2NKMkxObkFkemRVUnR4VTlZaDVQME9VNHJsN2hQcktQWGwtNHdiaGozZ3NoMjNxcWVGUHB3cjhYak02NWJTdXhNa1V3bmZ1eGVrRThiOG1EQXNPYUoxYW82ekhiajZSVXlhMl9CTHhaYThSbWh5enBLNWdMUGlDRnRYdUpoVEJIVnc?oc=5","date":"2026-02-28","type":"pipeline","source":"The Globe and Mail","summary":"Algorae Pharmaceuticals Seeks ASX Quotation for 7.4 Million New Shares - The Globe and Mail","headline":"Algorae Pharmaceuticals Seeks ASX Quotation for 7.4 Million New Shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPN19hRGVGVW5NdUpWcWlkWElUZXZLM2ZDTkgzeVBObzltZGdFYWI4RzBqNWthOFBiQXdyREF1WlJFQ0IyUW42RVZhMmxHR1ltZU5CbUlnUUZkcklvQ3BmMnNmS09pQ0Q1QnV3eERaU0I0WlktWHJDcXBvd3p1bDJNajB0d1EtMFFFb25jbjNuVUJta1JidVZ2VFpWU1FRWGd4QWVR?oc=5","date":"2026-02-18","type":"patent","source":"Contract Pharma","summary":"Pluri Biotech Secures China Patent for Immune Cell Tech - Contract Pharma","headline":"Pluri Biotech Secures China Patent for Immune Cell Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQOEkxb2liOWJEZG40THRuclJBVm1RbWxDRzRSZFBiVndSOEF2aG5kLTdlQUp4ZVBadHBQMFVDeFc2ZUw5NkNETW5KZnBmVmJ5aVBGelI5eDNyeDVhMmp4ZXlLU0thQVNNU3VZdHVoX1lWX01vTzJwSWxXS25EY0xZZ0NPWFN3Z3VDeGYwMkNfNGhWR3I3djJjTnFfUFU3a2d2VlhSaU9UMFcwY2xvRTlvM1NZNUROR1U?oc=5","date":"2025-12-10","type":"pipeline","source":"Pharmaceutical Technology","summary":"Cell and gene therapy investment strategy pivots as funding dries up - Pharmaceutical Technology","headline":"Cell and gene therapy investment strategy pivots as funding dries up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQbXhRTXBVQkJLQ28yOEdleVVKRVVneExFRGtJU1FmMFdEQXdQaUdoNWhscllDdlM2bWxNVzlFWTB5UGwtUXAydFA3V2NhRWZZVnRPdHlvSVd2OC1tRlA2MmlFZ3RBNk5yTjdXRVlIMTdxenhCUHVveGg2VmhtRVRNeW1YaGwzMlVWWS1rTUthbm9ESFZ0VGkwUkwzSmsxRFF3V3oxZmxBNE54QQ?oc=5","date":"2025-11-17","type":"deal","source":"Fierce Biotech","summary":"J&J buys into Halda's cell death tech with $3B acquisition, beefing up prostate cancer pipeline - Fierce Biotech","headline":"J&J buys into Halda's cell death tech with $3B acquisition, beefing up prostate cancer pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9xRGdDT0ZYOU1IbnM2YUJmLWVhSkdPOFFRLURBRXkyODgwcW9sb3VJamwtSE5oSVVNSjk2amRZUERzVnI4ZExkT1BvSDVtYmZjNHJXVmdXUS1mVWpyX1JRZnRueUF4Z9IBa0FVX3lxTE5PZGxNNkoxakRZZHQ4Q3AxT2ZtNG91QXd3LWE1NmMyUndKNGdOSW5GSFUwbGZaUGZFRGUtUzhGUS0wS09tZlZ1a0NjMEVLN1FzT2I4WHNrR2Z5MVY2NFpldGlUU19hVmJ1N1gw?oc=5","date":"2025-11-02","type":"regulatory","source":"BioInformant","summary":"Demand for Exosome Technologies Drives Billion Dollar Price Tags - BioInformant","headline":"Demand for Exosome Technologies Drives Billion Dollar Price Tags","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxPaUpjZWVBaHRGWXRIZ3Zibk1KT0pHaTNlUFd2aVhvaHZmSGFBcVBPeDVIdGQ1M2oyRVNWQ21wSVNqOXZseVNTX1lwU0lZcE9tbFVKVHlvVTUybzFiOFdHc1lialNhYXVmTHNzTHFRZGxRS1N3M2UzdUNDeXZvR3ZwTGJkdk1iaXJSWkVzT3NVZkUzWmJBM00tZEtuclVNMk52NUJqN1RGbjhCMjh1VmRRUmMtVElCZGtFZVI0UHd2bW81NmZjR3ZXZkZJY0JhWUtQZ0ZsbnpIbW11Q3BtQkhJeVhlQ1gwNFFlT2pzTFdZbVhJV3hkQTFVUktYQWdmSUJTSzdvbUFYT1Y1aW5UUHdEUW1jNy0wRU9Zb1R2MzJYNHZaeDhQODlYQkRDUG9kcExoa0dzWUxESktqY0hEMkZFQTVHQzJ2aGdKdURJUzNhMzA?oc=5","date":"2025-10-09","type":"regulatory","source":"Business Wire","summary":"Mesenchymal Stem Cells/Medicinal Signaling Cells Advances & Applications Report 2025: 1,670+ Trials, 12 Approvals Worldwide, and Path to 50 Approvals by 2040 - ResearchAndMarkets.com - Business Wire","headline":"Mesenchymal Stem Cells/Medicinal Signaling Cells Advances & Applications Report 2025: 1,670+ Trials, 12 Approvals Worldw","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5zS0czaGxKeXZQbkUzU3JnX3ZBcGFmbnVJcFcwZ3pYNGViU2FXa0F5b01ZOUNUQnQ5c3V0RERJbmZtS3Bnd1BVM1d5Zk1lMmtHNFNqQi0yVFhvVGxLT1p4MDhkLW1oTm1LbjRJ?oc=5","date":"2025-09-16","type":"pipeline","source":"KED Global","summary":"CHA Biotech aims to slash cost of gene and cell therapies to a tenth of current levels - KED Global","headline":"CHA Biotech aims to slash cost of gene and cell therapies to a tenth of current levels","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wJBVV95cUxOYUZ2YTFuMEluVzFfaERBTjNrRTQ5TThUM243RkFFblBzdFZ4NVJNUU8ybDJrZlpjbWo2WmJCa3BWTXBscWVSUmt2eTZmZTU1S0N4WTFHTnFENzU2NDNfVUk5em9KNWRXY3dKM0tlWExVUDVkNzZOQTFfZjR4U18xWkYxZTEtOUMzV1kwNFN0V3M0X1RyMWZlek01VkwwZVAzSXp1OGZVYlJOMHE5cGx1c3pWclN5YVQ2dXJodUJYTTBpTzRBcFkyelVKVTBSSHpNWW52d24yRV9mdk5vN25rQjdJWkc5ZkFqV0d0ZnlyUDFGZW5vVVFUelpYMHhuSFBudEloY0tHdTFXbzVkWnRSTW1MUzl1NHhWcE9ldTFmODhEWGw3T0FXeDVDTk9fTXZWX0htMzNVSzRrVDNDVWtSYnRoM3JrMVVrR05hYU1mN1ppMG0xeDhOOGdWYw?oc=5","date":"2025-09-08","type":"deal","source":"PR Newswire","summary":"Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-CT-1, an Autologous CAR-T Cell Therapy for Acute Myeloid Leukemia - PR Newswire","headline":"Made Scientific and Hemogenyx Pharmaceuticals Announce Technology Transfer and Manufacturing Partnership to Advance HG-C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPNXZmZzNaWjlPcXA0NU05Vm5sNkExOFZpb1g2WExhMXNSZ3pzM1lpUlBQVS1xNDRxSzY5UEFidlpxbDBmN1AxTHc0d0F0cUlTbXp2bWNVRndldkZ2RmxqU3FDR21VSENVa3ZmRUxweDRyYl9DLU5XUlZqemV3WHl3MVFqbjBWRUNFbm9xSjV0dFBWSDgyY243NU1wMzZMUHpWQzl5QlY5Tm4yOURpSVF5NjliQVFzV1U?oc=5","date":"2025-09-03","type":"regulatory","source":"Fierce Pharma","summary":"Ori's cell and gene platform wins key FDA advanced manufacturing designation - Fierce Pharma","headline":"Ori's cell and gene platform wins key FDA advanced manufacturing designation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPZEhoN2RTaHV5bk9qZC1kcUFWZGVhUFFxNE53amhGUXhPN1lHTEZuS19LTXR6Y2NTT01OV1JfODk4bzR0Nkd3LWxLbGtUMFlaVUs5YkJfbjA0VUlzNnhGcHNOcDE3UmlRMVRQRGp1ZlNnMmRJMS1DZVl6N1drZHZ0cVc3cXlLRzF3MHlObzJHcjE?oc=5","date":"2025-08-28","type":"pipeline","source":"Yahoo Finance","summary":"Takeda Pharmaceutical Company Limited (TAK) Advances γδ T Cell Cancer Treatments - Yahoo Finance","headline":"Takeda Pharmaceutical Company Limited (TAK) Advances γδ T Cell Cancer Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOOEVpcy1BTVpvNDEtTW9vNHBCSmZOYXZTOUlJaWE4ck5oTlRlTnBLZDRVNko4WmU1SGVBUW9ZRWxOdWxwRmpBWThIVE1kNm1XLWZnbTlZYkpOMnFMZXR4a2h0WTJVcTJHVmJWVDhEMDZQOGpDRFZOY0lvY1VLb2JRanZ4U1d5MFVqRGs3SkREczRIa01XYnlXNF8tbWVXT3dKTXRJTkhmRmpQNS11SUliV0Nfak5WNzlHbmZGbkVycURrZ0RQb2QzVmljRkxJV2RKN0xrQ1ZkVW1HVlo5Yi1US0xWeGJBLUVTRGlVeUxfem9wbVNRN01jNjNpUVB2VXhF?oc=5","date":"2025-08-07","type":"pipeline","source":"BioSpace","summary":"Stem Cell Therapy Market Size to Hit USD 78.39 Billion by 2032, Growing at a CAGR of 22.8% from 2025 to 2032 | Coherent Market Insights - BioSpace","headline":"Stem Cell Therapy Market Size to Hit USD 78.39 Billion by 2032, Growing at a CAGR of 22.8% from 2025 to 2032 | Coherent ","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}